ExesaLibero Pharma
Business Services · West Virginia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
781 Chestnut Ridge Rd Ste 400, Morgantow...Phone Number
(412) 296-3200Website
www.exesalibero-pharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ExesaLibero Pharma
ExesaLibero Pharma is focused on developing innovative small molecule drugs aimed at treating bone diseases, particularly those associated with conditions like rheumatoid arthritis and multiple myeloma. The company is currently conducting preclinical studies for its leading drug candidate, ELP-004, which targets bone erosion by suppressing osteoclast maturation. ExesaLibero collaborates with several academic institutions to enhance its research and development efforts. The ultimate goal is to secure FDA approval for clinical trials and improve the quality of life for individuals suffering from debilitating bone conditions.Explore more
Popular SearchesExesaLibero Pharma IncExesaliberoSIC Code 87,873NAICS Code 54,541Show more
ExesaLibero Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ExesaLibero Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ExesaLibero Pharma has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ExesaLibero Pharma
Product Launch: Get notified when ExesaLibero Pharma launches new products
Click to see if ExesaLibero Pharma had a recent Job posting/layoffs
Check if ExesaLibero Pharma has recently received funding, and reach out quickly before it becomes old news!
ExesaLibero Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on ExesaLibero Pharma recently announced quarterly report
Check out if ExesaLibero Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined ExesaLibero Pharma as Masked Content
Find more new buyers
Compare Similar Companies to ExesaLibero Pharma
Compare insights from companies similar to ExesaLibero Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ExesaLibero Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ExesaLibero Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ExesaLibero Pharma.
ExesaLibero Pharma Tech Stack
A closer look at the technologies used by ExesaLibero Pharma
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ExesaLibero Pharma
Sign Up For FreeTo access detailed company insights
ExesaLibero Pharma is focused on developing innovative small molecule drugs aimed at treating bone diseases, particularly those associated with conditions like rheumatoid arthritis and multiple myeloma. The company is currently conducting preclinical studies for its leading drug candidate, ELP-004, which targets bone erosion by suppressing osteocla... Read More
